Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAge Labs (BIOA) Non-Current Assets (2023 - 2026)

BioAge Labs' Non-Current Assets history spans 3 years, with the latest figure at $8.1 million for Q4 2025.

  • On a quarterly basis, Non-Current Assets rose 615.83% to $8.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $61.8 million, a N/A change, with the full-year FY2025 number at $8.1 million, up 615.83% from a year prior.
  • Non-Current Assets hit $8.1 million in Q4 2025 for BioAge Labs, down from $14.3 million in the prior quarter.
  • Over the last five years, Non-Current Assets for BIOA hit a ceiling of $20.5 million in Q2 2025 and a floor of $618000.0 in Q4 2023.
  • Historically, Non-Current Assets has averaged $9.2 million across 3 years, with a median of $8.1 million in 2025.
  • Biggest five-year swings in Non-Current Assets: soared 83.01% in 2024 and later surged 1460.39% in 2025.
  • Tracing BIOA's Non-Current Assets over 3 years: stood at $618000.0 in 2023, then skyrocketed by 83.01% to $1.1 million in 2024, then skyrocketed by 615.83% to $8.1 million in 2025.
  • Business Quant data shows Non-Current Assets for BIOA at $8.1 million in Q4 2025, $14.3 million in Q3 2025, and $20.5 million in Q2 2025.